• Abstracts can be submitted via the online Abstract Submission Service only, please don’t send abstract by email
• Abstract must be in English
• The deadline for abstract submission is now postponed to 30 November 2024 at 23:59:59 Central European Time. A Late-Breaking Abstract submission only for Posters will be available until 31 January 2025
• Abstracts submitted after this date will not be accepted
• PRESENTATION TYPE: Choose your preferred type of presentation between Oral Communication, Poster or both
• AUTHORS/AFFILIATIONS: you may enter up to 20 authors in the authors list and 20 affiliations. The presenting must be part of the authors list included in the submitted abstract. The names of authors will be published as listed on the submission form. Please make sure you have entered the full list of authors. The authors’ order and details (names, cities, country codes) will be published as entered in the form
• TOPIC: Choose one Topic:
  • Neisseriae: Clinical relevance and epidemiology in 2025
  • Meningococcal and gonococcal vaccines
  • Bacterial physiology and virulence, and in vivo & in vitro models
  • Clinical studies and translational Research and Correlates of protection
  • Antimicrobial resistance, therapeutics and diagnostics
  • Policy and cost-effectiveness
• TITLE: Title should not exceed 200 characters. Do not use abbreviations, spell out words and check that the title is complete in case you copy and paste it into the field. The entire title will be automatically capitalized
• TEXT: The text should not exceed 350 words and 3000 characters. Abstracts should be structured into the following headings: Background, Aim/Methods, Results, Conclusions.
• IMAGE: Only one image can be included in .jpg format. If you wish to add more than one image/table/graphics, you must prepare a single .jpg file and this should not exceed 200 Kbytes.
• KEYWORDS: Up to 5 keywords can be inserted
• Do not repeat authors, institutions, city and abbreviations in the title or in the text since the grading and selection process is blinded
• Do not include grant acknowledgements in the abstract content. Do not cite references in the abstract, as they are not allowed and will be deleted

Abstract will be accepted according to scientific merit
IPNC2025 allows the submission of abstracts for original contribution to the field only
Final selection of abstract will be made by the Scientific Committee by 18 January 2025.
All abstract contact authors will be then notified about the outcome (accepted or not accepted) of the review process.
Please ensure that the email provided during the abstract submission is accurate as all correspondences will be sent via email.

The late breaking abstracts submission will be open end of January 2025 to select a small amount of poster on the hotter topics.

NOTE:
Registration of presenting author is compulsory within 31 January 2025 to present an abstract during the Congress and to be published in the final programme and abstract book

Please note: before submitting an abstract, contact authors must register their data.

LATE-BREAKING POSTER SUBMISSION

Funding for researchers from Gavi-eligible countries
IPNC organizers and the Sclavo Vaccine Association ETS are pleased to offer a number of Travel Grants for researchers from Gavi-eligible countries selected by the Scientific Committee to present at the IPNC2025 Conference.
Presenters who qualify and wish to apply for a Grant must do so when submitting an abstract via the abstract submission portal.
The Grant can only be awarded once for one presenter per abstract.
This opportunity is only available for presenters living and working in one of the 54 GAVI-Eligible countries: https://www.gavi.org/types-support/sustainability/eligibility)

How it works
Travel grants are awarded on the basis of scientific merit using the evaluation process carried out by the Scientific Committee to present at the IPNC2025 Conference. While submitting an abstract, you can tick the Travel Grant application box. By doing so, you are indicating your interest in receiving a travel grant and that you are resident in a GAVI-Eligible country. Awardees will be notified about the Travel Grant before the end of 2024.
The Travel Grants include: airfare, car from the airport to the hotel and back, accommodation for 6 nights (30th March 2025- 4th April 2025) at a 3* hotel in close proximity to the conference venue and congress registration. The Sclavo Vaccine Association will bear these costs directly for the awardees.